Posts by: Patricia Inacio, PhD

Patricia Inacio, PhD

Patricia holds a Ph.D. in Cell Biology from University Nova de Lisboa, and has served as an author on several research projects and fellowships, as well as major grant applications for European Agencies. She has also served as a PhD student research assistant at the Department of Microbiology & Immunology, Columbia University, New York.

August 23, 2019August 23, 2019

Landos Biopharma Secures $60M Financing, Continues BT-11 Development for IBD

News

Landos Biopharma’s investigational BT-11 therapy for inflammatory bowel disease (IBD), including ulcerative colitis (UC) and Crohn’s disease (CD), is continuing testing in Phase 2 clinical trials — some of which ... Read more

July 12, 2019July 12, 2019

Th17 Immune Cells Raise Risk of Severe C. difficile in Colitis Patients, Study Shows

News

Patients with colitis are particularly susceptible to infection by the toxin-producing bacteria Clostridium difficile, but the reason remained unknown. Now, researchers have discovered that changes in the immune system, ... Read more

June 26, 2019June 26, 2019

Youngsters Diagnosed with IBD Have Increased Cancer Risk, Study Contends

News

Inflammatory bowel disease (IBD) diagnosis during childhood or adolescence may be linked with an increased risk for developing cancer, compared to the general population, according to results of a ... Read more

June 21, 2019June 21, 2019

First Patient Dosed in Phase 3 Trial of Etrasimod for Moderate to Severe UC

News

The Phase 3 trial ELEVATE UC 52 evaluating Arena Pharmaceuticals’ investigational therapy etrasimod for patients with moderately to severely active ulcerative colitis has dosed its first patient. “We are pleased ... Read more

April 17, 2019April 17, 2019

Entyvio Improves Quality of Life, Work Productivity of Ulcerative Colitis Patients, Phase 3 Study Shows

News

Treatment with Entyvio (vedolizumab), delivered into the blood or under the skin, led to significant clinical improvements and in quality of life, as well as work productivity in patients with ... Read more

March 22, 2019March 26, 2019

Ozanimod Lessens Inflammation in Crohn’s, Early Phase 2 Trial Data Show

News

Daily treatment with 1 mg of ozanimod reduced gut inflammation in patients with moderately to severely active Crohn’s disease, early data from the phase 2 STEPSTONE study show. B.G. ... Read more

March 11, 2019March 11, 2019

Plant-based Fasting-Mimicking Diet May Help Lessen IBD Severity

News

A short-term, plant-based fasting-mimicking diet followed by a normal diet lessened several of the hallmarks of inflammatory bowel disease (IBD), a study in a mouse model shows. The study, ... Read more

February 11, 2019February 11, 2019

‘Carbohydrate Monotony’ Diet May Ease IBD, Researchers Propose

News

A diet rich in multiple carbohydrate sources, including sugars, starchy carbohydrates, and dietary fiber, is a likely perpetrator of inflammatory bowel disease (IBD), two researchers believe. They say the ... Read more

January 28, 2019January 28, 2019

Pseudopolyps Do Not Predict Colorectal Cancer Risk in IBD Patients, 20-year Retrospective Study Shows

News

Pseudopolyps — large protrusions of the intestinal layer formed in the regenerative and healing phases of damaged tissue — are not predictors of risk for developing colorectal cancer among patients with ... Read more

January 9, 2019January 9, 2019

Malnutrition Puts Children with Crohn’s at Higher Risk of Post-surgery Complications, Study Says

News

Worsening degrees of malnutrition are directly linked to a higher risk of 30-day complications in children with Crohn’s disease who have undergone major bowel surgery, a study says. The ... Read more